We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Lonza enters development and manufacturing agreement with Genmab A/S for a novel antibody drug conjugate (ADC), HuMax-TF™Development and Manufacturing Agreement • October 25th, 2011
Contract Type FiledOctober 25th, 2011This agreement secures a development and cGMP manufacturing plan for Genmab A/S, a biotechnology company engaged in the development of human antibody therapeutics for the potential treatment of cancer